Verisk Responds to Delaware Chancery Court Ruling Regarding AccuLynx
JERSEY CITY, N.J., Aug. 10, 2026 (GLOBE NEWSWIRE) -- Verisk (Nasdaq: VRSK), a leading data analytics and technology provider to the global insurance industry, today issued the following statement in response to the Delaware Chancery Court ruling regarding AccuLynx:
Covered in this story
What has happened since
- Verisk Analytics is up 5.1% since this was published, 71 days ago.
Price move measured from the close nearest publication to the latest quote.
Analyst targets on Verisk Analytics
- RBC Capital Markets: $190 → $230 by Oct 2027 · Outperform via Investing.com
- Jefferies: $193 → $235 by Jul 2027 · Buy via Investing.com
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $VRSK yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Verisk Analytics →Summary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.